Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value
$180.39M
Total Bought
$5.02M
Total Sold
$823.0K
Net Transaction
+$4.20M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CYTOKINETICS INC(CYTK)588,357588,357019,43932,33617.93%+12,897
IRONWOOD PHARMACEUTICALS INC(IRWD)15,919,43515,919,435011,41720,85411.56%+9,437
NEUROCRINE BIOSCIENCES INC(NBIX)303,151303,151038,10342,55623.59%+4,453
REGENERON PHARMACEUTICALS(REGN)04,190+4,19002,3561.31%+2,356
LANTHEUS HLDGS INC(LNTH)96,251181,450+85,1997,8799,3075.16%+1,427
VOR BIOPHARMA INC(VOR)025,399+25,39901,2370.69%+1,237
AMARIN CORP PLC1,242,5271,242,527020,15420,35311.28%+199
VOR BIOPHARMA INC(VOR)508,0160-508,0168230—-823
INNOVIVA INC(INVA)2,816,0222,816,022056,57451,39228.49%-5,181
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q3 2025 | TickerTrail